Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models

Affiliations

• ¹ UCL Division of Surgery & Interventional Science, University College London, London, UK. v.stavrinides@ucl.ac.uk.
• ² The Alan Turing Institute, London, UK. v.stavrinides@ucl.ac.uk.
• ³ Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. v.stavrinides@ucl.ac.uk.
• ⁴ Department of Economics, Mathematics and Statistics, Birkbeck College, University of London, London, UK.
• ⁵ The Alan Turing Institute, London, UK.
• ⁶ Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
• ⁷ UCL Division of Surgery & Interventional Science, University College London, London, UK.
• ⁸ Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
• ⁹ Department of Applied Health Research, Institute of Epidemiology & Health, University College London, London, UK.
• ¹⁰ Division of Epidemiology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
• ¹¹ Department of Pathology, University College London Hospitals NHS Foundation Trust, London, UK.
• ¹² Centre for Medical Image Computing, University College London, London, UK.
• ¹³ Wellcome EPSRC Centre for Interventional & Surgical Science (WEISS), University College London, London, UK.
• ¹⁴ Department of Medical Physics and & Biomedical Engineering, University College London, London, UK.
• ¹⁵ Centre for Medical Imaging, University College London, London, UK.
• ¹⁶ Department of Urology, School of Medicine, Stanford School of Medicine, Stanford, CA, USA.
• ¹⁷ Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.